Want to take quizzes and track your credits?
Perioperative cardiac complications are the most widely feared medical issues for the anesthesiologist, surgeon, and medical consultant as they approach a patient in the perioperative period. Only recently have management strategies been addressed in high-quality studies. The following module explains the roles of medical and interventional treatments in lowering perioperative cardiac event rates. This module also discusses the typical presentation of coronary syndromes postoperatively and the management of antiplatelet and cardiac medications.
Sign in to take quiz and track your certificates
To help improve the quality of its educational content and meet applicable education accreditation requirements, the content provider will receive record of your participation and responses to this activity.
SHM Consults: Perioperative And Consultative Medicine curriculum can help you feel more confident about your knowledge and skills related to consultative medicine. Learn more
Accreditation Statement: The Society of Hospital Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Statement Designation: The Society of Hospital Medicine designates this activity for a maximum of 2.00 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Disclosure Statement: Author: Dr. Cohn reports having minor stock holdings in AstraZeneca, Bristol Myers Squibb, GlaxoSmithKline, Merck & Co, Inc, Pfizer Inc, and Portola; and serving on the Speakers Bureau for Janssen and Portola. Please note, there is an ongoing inquiry into publications involving Dr. Poldermans and his colleagues. The results of this inquiry may affect recommendations regarding perioperative use of β-blockers and statins. Editors (Leonard Feldman, MD, FACP, SFHM and Kurt Pfeifer, MD, FACP, SFHM): Dr. Feldman reports having no relevant financial or advisory relationships with corporate organizations related to this activity. Dr. Pfeifer reports having no relevant financial or advisory relationships with corporate organizations related to this activity. The planners and faculty for this activity have no relevant relationships to disclose unless otherwise listed.
SHM COI Policy: In accordance with the ACCME Standards for Commercial Support, SHM requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. SHM resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs. All relevant financial relationships shall be disclosed to participants prior to the start of the activity. Furthermore, SHM seeks to verify that all scientific research referred to, reported, or used in a continuing medical education (CME) activity conforms to the generally accepted standards of experimental design, data collection, and analysis. SHM is committed to providing its learners with high-quality CME activities that promote improvements in healthcare and not those of a commercial interest.
You currently have no searches saved.